Page last updated: 2024-08-23

sulfur and Carcinoma, Pancreatic Ductal

sulfur has been researched along with Carcinoma, Pancreatic Ductal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Aguirre, AJ; Biancur, DE; Chen, B; Das, NK; Del Rey, MQ; Gikandi, A; Hennessey, CJ; Huang, W; John, KM; Kapner, KS; Kuljanin, M; Lowder, KE; Malcolm, C; Mancias, JD; Nowak, JA; Poupault, C; Santana-Codina, N; Shah, YM; Yang, A; Zhang, H1
Aguirre, AJ; Cai, C; Cakir, Z; DeNicola, GM; Desousa, BR; Foakes, C; Hennessey, CJ; Hu, J; Jain, IH; Kuljanin, M; Mancias, JD; Perera, RM; Rademaker, G; Ravichandran, M; Shen, Y; Staes, AAL; Venida, A; Ward, NP; Yang, A; Yang, Y1

Other Studies

2 other study(ies) available for sulfur and Carcinoma, Pancreatic Ductal

ArticleYear
NCOA4-Mediated Ferritinophagy Is a Pancreatic Cancer Dependency via Maintenance of Iron Bioavailability for Iron-Sulfur Cluster Proteins.
    Cancer discovery, 2022, 09-02, Volume: 12, Issue:9

    Topics: Animals; Autophagy; Biological Availability; Carcinoma, Pancreatic Ductal; Ferritins; Humans; Iron; Iron-Sulfur Proteins; Mice; Nuclear Receptor Coactivators; Pancreatic Neoplasms; Sulfur; Transcription Factors

2022
Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS-MAPK Pathway Inhibition in Pancreatic Cancer.
    Cancer discovery, 2022, 09-02, Volume: 12, Issue:9

    Topics: Biological Availability; Carcinoma, Pancreatic Ductal; Humans; Iron; Iron-Sulfur Proteins; Nuclear Receptor Coactivators; Pancreatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Sulfur; Transcription Factors

2022